Methylxanthines and benzodiazepines are among the most widely used behaviorally active drugs in contemporary society. Research is proposed to systematically investigate pharmacological and environmental factors that mediate their effects on behavior. The behavioral actions of methylxanthines will be investigated by: 1) determining their effects on schedule-controlled behavior of monkeys under conditions in which caffeine produces marked increases in response rate, 2) directly comparing their effects with those of prototypical psychomotor-stimulant drugs, 3) determining their effects in combination with selected derivatives of adenosine that block methylxanthine-induced increases in responding, and 4) evaluating their reinforcing effects under conditions in which caffeine maintains persistent self-administration. The behavioral actions of benzodiazepines and of newly developed drugs with putative antianxiety activity will be investigated by: 1) determining their effects on schedule-controlled behavior under conditions that distinguish antiznxiety drugs from other pharmacologic classes, 2) evaluating their stimulus effects under conditions in which benzodiazepines exert discriminative control over behavior, and 3) determining their effects in combination with selective benzodiazepine antagonists. The interactions between antianxiety drugs, methylxanthines, and derivatives of adenosine will be investigated under conditions in which methylxanthines enhance and adenosine derivatives block the characteristic effects of benzodiazepines. The proposed studies will provide needed information about how methylxanthines and benzodiazepines alter and control behavior.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002658-08
Application #
3207483
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1980-09-01
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
8
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
George, Mark S; Sackeim, Harold A (2008) Brain stimulation, revolutions, and the shifting time domain of depression. Biol Psychiatry 64:447-8
Howell, L L; Coffin, V L; Spealman, R D (1997) Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology (Berl) 129:1-14
Wettstein, J G; Teeple, E S; Morse, W H (1993) Combination of buspirone and other drugs with beta-CCE in monkeys: effects on respiration and behavior. Pharmacol Biochem Behav 44:633-41
Wettstein, J G; Teeple, E S; Morse, W H (1990) Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys. J Pharmacol Exp Ther 255:1328-34
Spealman, R D (1990) Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology (Berl) 101:142-5
Wettstein, J G (1990) Unusual behavioral profile of alprazolam in squirrel monkeys. J Pharmacol Exp Ther 253:1070-6
Howell, L L; Morse, W H; Spealman, R D (1990) Respiratory effects of xanthines and adenosine analogs in rhesus monkeys. J Pharmacol Exp Ther 254:786-91
Coffin, V L; Spealman, R D (1989) Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: comparison with caffeine and 7-(2-chloroethyl) theophylline. Eur J Pharmacol 170:35-40
France, C P; Morse, W H (1989) Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys. J Pharmacol Exp Ther 250:928-36
Bergman, J; Madras, B K; Johnson, S E et al. (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-5

Showing the most recent 10 out of 36 publications